These markers include CRP and IL-6; the study concluded that depression and anxiety in RA patients were driven by the same immune-inflammatory pathway which is part of the pathophysiology of RA disease itself, and not driven by the experience and burden of the disease (28). This evidence concerns the gene IL6 and depressive symptom measurement.